Inogen (INGN) Cash from Investing Activities (2013 - 2026)

Inogen (INGN) reported Cash from Investing Activities of -$2.0 million for Q1 2026, up 3.09% year-over-year from -$1.9 million in Q1 2025, and down 30.28% quarter-over-quarter from -$1.5 million in Q4 2025.

Inogen (INGN) Cash from Investing Activities (2013 - 2026) Analysis & Trends

Inogen (INGN) has 14 years of Cash from Investing Activities data on file, last reported at -$2.0 million in Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at -$2.0 million, up 3.09% year-over-year; the trailing twelve-month figure through Mar 2026 was -$26.1 million (down 917.75% YoY), and the FY2025 annual result was -$26.2 million, down 87.54% from the prior year.
  • Cash from Investing Activities fell to -$2.0 million in Q1 2026 per INGN's latest filing, from -$1.5 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $11.5 million in Q4 2024 and troughed at -$45.8 million in Q3 2023.
  • A 5-year average of -$6.6 million and a median of -$2.0 million in 2025 frame the typical range for Cash from Investing Activities.
  • The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities soared 210.57% in 2022, then tumbled 2191.85% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$6.9 million in 2022, then jumped by 159.45% to $4.1 million in 2023, then jumped by 179.55% to $11.5 million in 2024, then slumped by 113.14% to -$1.5 million in 2025, then plunged by 30.28% to -$2.0 million in 2026.
  • Business Quant data shows INGN's Cash from Investing Activities at -$2.0 million in Q1 2026, -$1.5 million in Q4 2025, and -$82000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -20.32 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -185.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -816.00 Mn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -92.80 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -475.32 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -298.50 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -2.50 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -217.20 Mn
10 Inogen 176.23 Mn 81.82 Mn 37.86 Mn -1.98 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.98 Mn
Mar 31, 2026 -1.98 Mn
Dec 31, 2025 -1.52 Mn
Dec 31, 2025 -1.52 Mn
Sep 30, 2025 -82,000.00
Sep 30, 2025 -82,000.00
Jun 30, 2025 -22.57 Mn
Jun 30, 2025 -22.57 Mn
Mar 31, 2025 -2.04 Mn
Mar 31, 2025 -2.04 Mn
Dec 31, 2024 11.54 Mn
Dec 31, 2024 11.54 Mn
Sep 30, 2024 305,000.00
Sep 30, 2024 305,000.00
Jun 30, 2024 -12.38 Mn
Jun 30, 2024 -12.38 Mn
Mar 31, 2024 -13.44 Mn
Mar 31, 2024 -13.44 Mn
Dec 31, 2023 4.13 Mn
Dec 31, 2023 4.13 Mn